Document ID: chunk:federal_register_of_legislation:F2019L01096:reg:7
Version: federal_register_of_legislation:F2019L01096
Segment Type: reg
Provision Reference: reg 7
Character Range: 1702–3526

7               Kind of injury, disease or death to which this Statement of Principles relates
(1)          This Statement of Principles is about malignant neoplasm of the bladder and death from malignant neoplasm of the bladder.
Meaning of malignant neoplasm of the bladder
(2)          For the purposes of this Statement of Principles, malignant neoplasm of the bladder:
(a)          means a primary malignant neoplasm arising from the epithelial cells of the urinary bladder, including the ureteric orifice and the urethral orifice of the bladder; and
(b)          includes urothelial carcinoma (also known as transitional cell carcinoma), squamous cell carcinoma, adenocarcinoma, small cell carcinoma and carcinoma in situ; and
(c)          excludes soft tissue sarcoma, carcinoid tumour, non-Hodgkin lymphoma and Hodgkin's lymphoma.
(3)          While malignant neoplasm of the bladder attracts ICD‑10‑AM code C67 or D09.0, in applying this Statement of Principles the meaning of malignant neoplasm of the bladder is that given in subsection (2).
(4)          For subsection (3), a reference to an ICD-10-AM code is a reference to the code assigned to a particular kind of injury or disease in The International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, Australian Modification (ICD-10-AM), Tenth Edition, effective date of 1 July 2017, copyrighted by the Independent Hospital Pricing Authority, ISBN 978-1-76007-296-4.
Death from malignant neoplasm of the bladder
(5)          For the purposes of this Statement of Principles, malignant neoplasm of the bladder, in relation to a person, includes death from a terminal event or condition that was contributed to by the person's malignant neoplasm of the bladder.
Note: terminal event is defined in the Schedule 1 – Dictionary.